157 related articles for article (PubMed ID: 17660166)
1. Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients.
Rizzo M; Rini GB; Berneis K
Adv Ther; 2007; 24(3):575-82. PubMed ID: 17660166
[TBL] [Abstract][Full Text] [Related]
2. Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe.
Yamazaki D; Ishida M; Watanabe H; Nobori K; Oguma Y; Terata Y; Koyama T; Iino K; Kosaka T; Ito H
Lipids Health Dis; 2013 Feb; 12():9. PubMed ID: 23374898
[TBL] [Abstract][Full Text] [Related]
3. Newer pharmaceutical agents to treat lipid disorders.
Davidson MH
Curr Cardiol Rep; 2003 Nov; 5(6):463-9. PubMed ID: 14558988
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.
Torimoto K; Okada Y; Mori H; Hajime M; Tanaka K; Kurozumi A; Narisawa M; Yamamoto S; Arao T; Matsuoka H; Inokuchi N; Tanaka Y
Lipids Health Dis; 2013 Sep; 12():137. PubMed ID: 24053480
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
Bays HE; Davidson MH; Massaad R; Flaim D; Lowe RS; Tershakovec AM; Jones-Burton C
Am J Cardiol; 2011 Aug; 108(4):523-30. PubMed ID: 21596364
[TBL] [Abstract][Full Text] [Related]
6. The clinical relevance of low-density-lipoproteins size modulation by statins.
Rizzo M; Berneis K
Cardiovasc Drugs Ther; 2006 Jun; 20(3):205-17. PubMed ID: 16775666
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
8. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment of a Sardinian patient affected by Autosomal Recessive Hypercholesterolemia (ARH).
Muntoni S; Pisciotta L; Muntoni S; Bertolini S
J Clin Lipidol; 2015; 9(1):103-6. PubMed ID: 25670367
[TBL] [Abstract][Full Text] [Related]
11. Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.
Ason B; Tep S; Davis HR; Xu Y; Tetzloff G; Galinski B; Soriano F; Dubinina N; Zhu L; Stefanni A; Wong KK; Tadin-Strapps M; Bartz SR; Hubbard B; Ranalletta M; Sachs AB; Flanagan WM; Strack A; Kuklin NA
J Lipid Res; 2011 Apr; 52(4):679-87. PubMed ID: 21262787
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
Fabbri G; Maggioni AP
Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Oct; 22(10):2037-9. PubMed ID: 17022863
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance?
Rizzo M; Berneis K; Spinas GA; Rini GB; Kapur NK
Int J Clin Pract; 2009 Mar; 63(3):478-85. PubMed ID: 19222633
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin increased serum osteocalcin levels independent of its serum cholesterol-lowering effect in patients with type 2 diabetes and hypercholesterolemia.
Kanazawa I; Yamaguchi T; Yamauchi M; Sugimoto T
Intern Med; 2009; 48(21):1869-73. PubMed ID: 19881236
[TBL] [Abstract][Full Text] [Related]
16. Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease.
Li M; Al-Sarraf A; Mattman A; Frohlich J
BMJ Case Rep; 2012 Apr; 2012():. PubMed ID: 22604766
[TBL] [Abstract][Full Text] [Related]
17. Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial.
Ju SH; Lim JY; Song M; Kim JM; Kang YE; Yi HS; Joung KH; Lee JH; Kim HJ; Ku BJ
Front Endocrinol (Lausanne); 2024; 15():1336357. PubMed ID: 38586464
[TBL] [Abstract][Full Text] [Related]
18. The future direction of cholesterol-lowering therapy.
Evans M; Roberts A; Rees A
Curr Opin Lipidol; 2002 Dec; 13(6):663-9. PubMed ID: 12441891
[TBL] [Abstract][Full Text] [Related]
19. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
